2016年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南 - Suppr | 超能文献

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

作者信息

Ponikowski Piotr, Voors Adriaan A, Anker Stefan D, Bueno Héctor, Cleland John G F, Coats Andrew J S, Falk Volkmar, González-Juanatey José Ramón, Harjola Veli-Pekka, Jankowska Ewa A, Jessup Mariell, Linde Cecilia, Nihoyannopoulos Petros, Parissis John T, Pieske Burkert, Riley Jillian P, Rosano Giuseppe M C, Ruilope Luis M, Ruschitzka Frank, Rutten Frans H, van der Meer Peter

出版信息

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167. doi: 10.1016/j.rec.2016.11.005.

DOI:10.1016/j.rec.2016.11.005

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.2016年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167. doi: 10.1016/j.rec.2016.11.005.

2

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会（HFA）特别贡献制定。

Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.

3

[The new ESC Guidelines for acute and chronic heart failure 2016].[2016年欧洲心脏病学会急性和慢性心力衰竭新指南]

Herz. 2016 Dec;41(8):655-663. doi: 10.1007/s00059-016-4496-3.

4

2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.2010年欧洲心脏病学会（ESC）心力衰竭器械治疗指南重点更新：2008年ESC急慢性心力衰竭诊断和治疗指南以及2007年ESC心脏再同步化治疗指南的更新。由心力衰竭协会和欧洲心律协会特别贡献制定。

Eur J Heart Fail. 2010 Nov;12(11):1143-53. doi: 10.1093/eurjhf/hfq192.

5

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).《2008年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》：欧洲心脏病学会2008年急性和慢性心力衰竭诊断与治疗特别工作组制定。与欧洲心脏病学会心力衰竭协会（HFA）合作编写，并得到欧洲重症监护医学学会（ESICM）认可。

Eur J Heart Fail. 2008 Oct;10(10):933-89. doi: 10.1016/j.ejheart.2008.08.005. Epub 2008 Sep 16.

6

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》：欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组。与欧洲心脏病学会心力衰竭协会（HFA）合作制定。

Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105.

7

Heart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline.南非心力衰竭学会（HeFSSA）对欧洲心脏病学会（ESC）2012 年慢性心力衰竭指南的看法。

S Afr Med J. 2013 Jul 29;103(9 Suppl 2):660-7. doi: 10.7196/samj.7319.

8

[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].[2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南]

Turk Kardiyol Dern Ars. 2012 Oct;40 Suppl 3:77-137.

9

[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].[2016年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南]

Kardiol Pol. 2016;74(10):1037-1147. doi: 10.5603/KP.2016.0141.

10

A plea for an early ultrasound-clinical integrated approach in patients with acute heart failure. A proactive comment on the ESC Guidelines on Heart Failure 2016.呼吁在急性心力衰竭患者中早期采用超声-临床综合治疗方法。对 2016 年 ESC 心力衰竭指南的积极评论。

Int J Cardiol. 2017 Oct 15;245:207-210. doi: 10.1016/j.ijcard.2017.07.013.

引用本文的文献

1

Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.肌病和肌肉萎缩症的综合治疗方法：分子机制、诊断及未来疗法

Int J Mol Sci. 2025 Aug 18;26(16):7972. doi: 10.3390/ijms26167972.

2

Effects of severe scoliosis on cardiac structure and function in resting patients: a retrospective study.重度脊柱侧弯对静息状态患者心脏结构和功能的影响：一项回顾性研究。

J Orthop Surg Res. 2025 Jul 19;20(1):681. doi: 10.1186/s13018-025-06113-3.

3

Evaluation of the prognosis of elderly patients with heart failure by Monocyte-to-High-Density Lipoprotein Ratio, Neutrophil Gelatinase-Associated Lipocalin, and Angiotensin II.通过单核细胞与高密度脂蛋白比值、中性粒细胞明胶酶相关脂质运载蛋白和血管紧张素II评估老年心力衰竭患者的预后

Front Cardiovasc Med. 2025 Jun 16;12:1609798. doi: 10.3389/fcvm.2025.1609798. eCollection 2025.

4

Heart failure medication treatment and prognosis: a retrospective cross-sectional study.心力衰竭药物治疗与预后：一项回顾性横断面研究。

Front Pharmacol. 2025 Jun 12;16:1532123. doi: 10.3389/fphar.2025.1532123. eCollection 2025.

5

An Innovative Artificial Intelligence Classification Model for Non-Ischemic Cardiomyopathy Utilizing Cardiac Biomechanics Derived from Magnetic Resonance Imaging.一种利用磁共振成像衍生的心脏生物力学的非缺血性心肌病创新人工智能分类模型。

Bioengineering (Basel). 2025 Jun 19;12(6):670. doi: 10.3390/bioengineering12060670.

6

Circulating Extracellular Vesicles Predict Complications after Cardiac Surgery.循环细胞外囊泡可预测心脏手术后的并发症。

J Cardiovasc Transl Res. 2025 Jun 23. doi: 10.1007/s12265-025-10642-x.

7

Factors influencing major adverse cardiac events among people with acute coronary syndrome admitted to a tertiary hospital in Northeastern Thailand: A cross-sectional study.泰国东北部一家三级医院收治的急性冠状动脉综合征患者发生主要不良心脏事件的影响因素：一项横断面研究。

Belitung Nurs J. 2025 Apr 19;11(2):232-239. doi: 10.33546/bnj.3672. eCollection 2025.

8

Relationship between serum uric acid and ventricular diastolic dysfunction in type 2 diabetes mellitus patients.2型糖尿病患者血清尿酸与心室舒张功能障碍的关系

Am J Transl Res. 2025 Mar 15;17(3):2057-2066. doi: 10.62347/CAIV7004. eCollection 2025.

9

The real-world anti-inflammatory effect of SGLT2i in patients with chronic heart failure.钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）在慢性心力衰竭患者中的真实世界抗炎作用。

J Med Life. 2025 Feb;18(2):155-164. doi: 10.25122/jml-2025-0011.

10

The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction.雌激素在射血分数保留的心力衰竭危险因素性别差异中的作用。

Biol Direct. 2025 Mar 10;20(1):28. doi: 10.1186/s13062-025-00618-x.